Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369407 · ClinicalTrials.gov registry record
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 400
- Enrollment target
NCT01369407: Completed study, sponsored by University of Michigan.
NCT01369407 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01369407 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
REVIVAL will establish a prospective, observational, multicenter patient cohort in ambulatory patients with chronic, advanced, systolic heart failure that will provide a greater understanding of their clinical trajectory (rates of hospitalizations, transplantation, MCSD use and death), and of how baseline clinical risk measures are related to prognosis.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-08-29 |
What the finished NCT01369407 record still lists
NCT01369407 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01369407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01369407 about?
NCT01369407 is a clinical study titled "REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE". REVIVAL will establish a prospective, observational, multicenter patient cohort in ambulatory patients with chronic, advanced, systolic heart failure that will provide a greater understanding of their clinical trajectory (rates of hospitalizations, transplantation, MCSD use and death), and of how ba...
What is the current status of trial NCT01369407?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2015-07. Estimated completion is 2018-08-29.
What interventions are being tested in trial NCT01369407?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT01369407?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia